Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02780128
Title Next Generation Personalized Neuroblastoma Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yael P Mosse
Indications

neuroblastoma

Therapies

Siremadlin

Ceritinib + Ribociclib

Trametinib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.